טוען...
Risk Management for BRCA1/BRCA2 mutation carriers without and with breast cancer
PURPOSE OF REVIEW: We review the management for unaffected BRCA1/2 mutation carriers and the local management of early stage breast cancer. RECENT FINDINGS: For unaffected BRCA1/2 mutation carriers, surveillance includes annual magnetic resonance imaging (MRI) and mammogram (MG). Novel imaging modal...
שמור ב:
| הוצא לאור ב: | Curr Breast Cancer Rep |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7863621/ https://ncbi.nlm.nih.gov/pubmed/33552388 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12609-019-00350-2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|